Back to Search
ROBYN ROYAL, PH.D. L. AC., DIPL.
PH.D. L. AC., DIPL.
Acupuncturist
NPI: 1134905805Individual
Specialties, Licenses & Credentials
AcupuncturistPrimary
Acupuncturist
Code: 171100000X
167141(WA)
Research & Publications (20)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
PMID 19451549·Blood·2009
3-trial
Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.
PMID 19434456·Ann Surg Oncol·2009
8-other
Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.
PMID 19050961·Ann Surg Oncol·2009
8-other
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
PMID 18809613·J Clin Oncol·2008
3-trial
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines.
PMID 18765555·Clin Cancer Res·2008
8-other
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006.
PMID 18457330·Cancer·2008
8-other
Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum.
PMID 18396204·Semin Oncol·2008
6-review
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy.
PMID 18172279·Clin Cancer Res·2008
7-preclinical
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.
PMID 17982122·Clin Cancer Res·2007
2-rct
Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma.
PMID 17942922·Cancer Res·2007
7-preclinical
Determination of the elimination half-life of fibroblast growth factor-23.
PMID 17374707·J Clin Endocrinol Metab·2007
8-other
Cancer regression in patients after transfer of genetically engineered lymphocytes.
PMID 16946036·Science·2006
3-trial
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
PMID 16710025·J Clin Oncol·2006
8-other
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
PMID 16283570·Ann Surg Oncol·2005
3-trial
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.
PMID 16237114·J Immunol·2005
8-other
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
PMID 16087944·J Clin Oncol·2005
3-trial
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
PMID 15800326·J Clin Oncol·2005
3-trial
Effect of caesarean section on breast milk transfer to the normal term newborn over the first week of life.
PMID 12937041·Arch Dis Child Fetal Neonatal Ed·2003
4-observational
Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
PMID 12490843·Surgery·2002
8-other
Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs.
PMID 12140736·Gene Ther·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1201 SECOND STREET
SAINT THOMAS, VI 00802 - Phone
- (340) 244-9743
Quick Facts
- NPI
- 1134905805
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile